adplus-dvertising
Connect with us

News

Canada secures 2 new deals for possible COVID-19 vaccines – Global News

Published

 on


Canada has inked two additional deals with companies working on a possible vaccine for COVID-19.

The two agreements include 76 million doses of Novavax Inc.’s vaccine candidate and 38 million doses of Johnson & Johnson’s candidate.






1:12
Coronavirus: Government focus is on Canadians’ access to potential COVID-19 vaccine, Trudeau says


Coronavirus: Government focus is on Canadians’ access to potential COVID-19 vaccine, Trudeau says

They bring Canada’s total number of procurement agreements with vaccine developers to four, as deals with Pfizer Canada and Moderna were announced earlier this month.

Story continues below advertisement

Read more:
Canadians could join clinical trials for new COVID-19 vaccine, says researcher

Prime Minister Justin Trudeau acknowledged Monday that there is “a lot more work to go” on the development of any of these vaccines, but said the “broad range of vaccine developers” Canada has signed on with will be beneficial in the long run.

“It’s possible there will be a breakthrough soon, but we don’t know where or when that breakthrough will be,” he said.






0:44
Coronavirus: Trudeau announces 2 new deals for possible COVID-19 vaccines


Coronavirus: Trudeau announces 2 new deals for possible COVID-19 vaccines

“Taken together, our vaccine agreements will give Canada at least 88 million doses with options to obtain tens of millions more.”

Some vaccines may require more than one dose to be effective. Any potential vaccine will be required to pass Health Canada regulatory approval before being distributed.

Story continues below advertisement






2:24
Coronavirus: Canada inks deals with Pfizer, Moderna for coronavirus vaccine candidates


Coronavirus: Canada inks deals with Pfizer, Moderna for coronavirus vaccine candidates

Novavax — a biotechnology company that develops vaccines for serious infectious diseases — said it expects to finalize the advance purchase agreement “as early as the second quarter of 2021.”

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

Novavax’s vaccine (NVX-CoV2373) is currently in its second phase of clinical trials. The company plans to begin the third phase in September.

Johnson & Johnson’s vaccine is currently in phase one and two of its trials in the U.S. and Belgium. In a statement, the company said plans for phase three of the program are already underway, which will include trials on 60,000 volunteers.






2:06
Government of Canada makes vaccine deals with 2 more companies


Government of Canada makes vaccine deals with 2 more companies

Clinical trials by Pfizer Canada, which is working with BioNTech in Germany, and U.S.-based Moderna, have both already advanced to the third stage.

Story continues below advertisement

Canada has requested 20 million and 56 million doses of those candidates, respectively.

Read more:
Canada’s top doctor ‘optimistic’ after Canada-China vaccine partnership collapses

Monday’s announcement is the first glimpse of how many vaccine doses the federal government is working to secure as the coronavirus pandemic continues in Canada. Previously, officials did not elaborate on the number of doses it was requesting from companies, merely saying “millions.”

The cost of the agreements is not yet clear.

Novavax’s vaccine has shown promise in recent weeks. Initial data from an early-stage trial this month exhibited an ability to produce antibodies against COVID-19.

The company recently began enrolling volunteers for its second phase candidate, with data from that part of the clinical trial expected in the fourth quarter of 2020.






2:36
Should the COVID-19 vaccine be patent-free?


Should the COVID-19 vaccine be patent-free?

Globally, the Novavax vaccine is one of nearly 30 being tested in human clinical trials. However, it lags behind candidates from Pfizer, Moderna and AstraZeneca, which are in later stages at this time.

Story continues below advertisement

The United States and Britain are also in deals with Novavax. The U.S. awarded the company $1.6 billion in July to test and manufacture its vaccine in the country, with the hopes of securing 100 million doses by January. Britain has requested to buy 60 million doses.

Johnson & Johnson’s vaccine uses “viral vectors” to generate immune responses. A similar approach is being taken by AstraZeneca, as well as China’s CanSino, which was once being developed in partnership with Canada but has since been abandoned.

Read more:
Safety of COVID-19 vaccine concerning some Canadians, StatCan survey shows

The government also announced on Monday that it would provide $126 million in funding to expand a biomanufacturing facility at the Human Health Therapeutics Research Centre in Montreal.






0:46
Coronavirus: Trudeau announces over $126 million funding to NRC biomanufacturing facility for vaccine production


Coronavirus: Trudeau announces over $126 million funding to NRC biomanufacturing facility for vaccine production

Trudeau said the aid would bolster the facility’s ability to manufacture vaccines and strengthen partnerships with developers. It is expected to be up-and-running by mid-2021, Trudeau said, and intends to produce up to two million doses of vaccine a month by the end of next summer.

Story continues below advertisement

Anita Anand, the minister of public services and procurement, in a statement called the in-principle agreement “an important step” in the government’s efforts to secure a vaccine as the pandemic continues and “evolves.”

As of Aug. 30, the coronavirus pandemic has claimed 9,117 lives in Canada overall, and 127,870 cases have been diagnosed, according to figures released by provincial and territorial governments.

The vast majority of people diagnosed — about 89 per cent — have recovered from the viral illness.

More than 6.3 million tests have been conducted since late January.

— with files from Reuters, the Canadian Press and Global News’ Kerri Breen

© 2020 Global News, a division of Corus Entertainment Inc.

Let’s block ads! (Why?)

728x90x4

Source link

News

Progressive Conservatives hold onto seat in eastern Ontario byelection

Published

 on

The Progressive Conservatives have won a provincial byelection in eastern Ontario, retaining a seat previously held by a popular cabinet minister.

The Bay of Quinte provincial byelection today was held just one month after Todd Smith resigned the seat.

Voters have chosen to send Progressive Conservative candidate Tyler Allsopp to represent them in the legislature.

He has captured about 38 per cent of the vote, with most polls reporting, compared to about 33 per cent for Liberal candidate Sean Kelly.

Both candidates are municipal councillors in Belleville.

Smith won four successive elections in the region for the Tories, securing nearly 50 per cent of the vote in the last two elections, but some experts and polls suggested it may be a closer race this time around.

NDP candidate Amanda Robertson is trailing Allsopp and Kelly in third, with Green Party of Ontario candidate Lori Borthwick in a distant fourth.

This report by The Canadian Press was first published Sept. 19, 2024.

The Canadian Press. All rights reserved.



Source link

Continue Reading

News

Veteran linebacker Wynton McManis returns to Argos defence to face Ticats

Published

 on

TORONTO – Wynton McManis will get a second shot at the Hamilton Tiger-Cats.

The veteran linebacker returns Friday night when the Toronto Argonauts (7-6) host Hamilton (4-9). McManis missed six games with a groin injury.

“Man, that’s tough as hell,” said McManis, a trademark toothpick in his mouth. “Just seeing your brothers going out there and competing and laying it all on the line and feeling you have something to offer or want to offer something to be able to help, it’s hard.

“But we’re here now, they held it down … and I’m ready to go.”

The six-foot-one, 225-pound McManis registered 33 tackles, two special-teams tackles, a sack, interception and touchdown over Toronto’s first seven regular-season games. McManis, a Memphis, Tenn., native, has been a CFL all-star the last two seasons and helped Toronto win the ’22 Grey Cup.

Toronto comes off a solid 33-17 road win over B.C. last week. Its defence had seven sacks, including three from Ralph Holley, who’s tied for the league lead with seven overall.

“It brings a lot,” Toronto head coach Ryan Dinwiddie said of McManis’s return. “A lot of energy, a lot of focus, communication, it’s great for our lockerroom.

“He was with us in B.C. last week and shows veteran leadership even from the sidelines. We’re very excited to have him back … he’ll have a different energy.”

Especially facing Hamilton after being forced to miss the annual Labour Day showdown, which Hamilton won 31-28 on Sept. 2. McManis will also celebrate his 30th birthday Friday.

“Yeah, that’s fun,” McManis said with a grin. “It’s perfect.”

Hamilton can sweep the three-game series with a victory. But more importantly, the Ticats would pull to within four points of third-place Toronto with both teams having four regular-season contests remaining.

Conversely, a Toronto win would push Hamilton eight points back and deal its thin playoff hopes a severe blow.

“It’s an important game because it’s the next one,” McManis said. “But we understand what comes with it, we understand the importance of winning to reach our goals.

“It’s a playoff game for us.”

Hamilton has clinched the season series with Toronto but hasn’t recorded the sweep since 2019. The Argos also have much to play for as they’re currently just three points behind Ottawa (8-4-1), which hosts first-place Montreal (10-2-1) on Saturday.

Hamilton leads the CFL in net offensive yards (395.1 per game) and passing (321 per game). Veteran quarterback Bo Levi Mitchell has thrown for 3,682 and 23 TDs — both league highs — but also surrendered 13 interceptions (tied for most).

Mitchell is 14-2 all-time versus Toronto. Hamilton receiver Tim White has 11 catches for 246 yards and two TDs versus the Argos this season while Steven Dunbar Jr. had eight receptions for 151 yards and a touchdown in last week’s 31-27 win over Ottawa.

Running back Greg Bell, who ran for 99 yards and a TD versus Ottawa, is out with an Achilles injury. However, veteran James Butler, twice a 1,000-yard rusher, returns to the lineup.

“James Butler is a great running back in this league,” McManis said. “He and I have had some great battles throughout the years and this season so it will be a fun one.”

Toronto will be minus Janarion Grant (chest), who has a league-best four return TDs this season (three punt, one kickoff).

“We’re going to lose a little bit . . . Janarion has been pretty special and I think he’s up there with the best returners in CFL history,” Dinwiddie said. “We’ve got to find a way to play good football on offence and defence to where special teams doesn’t have to carry us.”

Hamilton head coach Scott Milanovich said his team heads into Friday’s contest in a good place.

“I think winning certainly helps the mood, the energy, the belief, the faith in what we’re doing,” he told Hamilton reporters this week. “They’re believing, they’re practising hard and they’re starting to see the fruits of those labours.”

Milanovich said Hamilton’s keys to success on Friday remain unchanged.

“It’s about protecting the football, penalties and explosive plays, protecting the quarterback and hitting their quarterback,” he said. “It’s never going to change.

“The last couple of weeks we’ve started to get that and hopefully we can keep it going.”

Toronto’s Chad Kelly is averaging 344 passing yards in his four starts this season and has won four of five career games versus Hamilton. Since 2021, the Argos are 10-4 against the Ticats, including 6-0 at BMO Field.

“Really, we just don’t want to lose this game,” Dinwiddie said. “We’ve got to stack up some wins to get ourselves locked into the playoffs and maybe try and get a home playoff game.

“Now, there will be a little added rivalry and I think the game will be physical. I know they’re feeling confident, they’ve beat us twice and we can’t take them lightly.”

Added McManis: “It’s like a self-esteem, self-respect type of thing at this point in the season. Who do you want to be? You should understand that. We go into each game each week wanting to win and put our best foot forward and put the best version of the Toronto Argonauts on the field.”

This report by The Canadian Press was first published Sept. 19, 2024.



Source link

Continue Reading

News

Ashleigh Buhai leads on LPGA Tour and Nelly Korda shows no sign of Solheim fatigue

Published

 on

MAINEVILLE, Ohio (AP) — Nelly Korda had a tough time getting out of bed Thursday morning. Any Solheim Cup fatigue had no bearing on her standard of golf, a bogey-free 67 in the Kroger Queen City Championship that left her two shots behind Ashleigh Buhai.

Korda and Leona Maguire, who also had a 5-under 67, are among 11 players who competed in the Solheim Cup last week and got right back to work at the TPC River’s Bend. Savannah Grewal of Mississauga, Ont., also had a 67 on the day to be tied for fourth.

Buhai, a former Women’s British Open champion from South Africa, isn’t part of the Solheim Cup and had a few weeks to rest from an injury-plagued season. She ran off eight birdies for her 7-under 65, giving her a one-shot lead over Jeeno Thitikul and Yan Liu.

“Just shows that rest is just as important,” Buhai said. “I know if I give myself five days to warm up, with my coach coming in, we did good work, and, yeah, it was nice to actually just see it pay off today.”

Korda at least had the afternoon for nap time after her early start. She went 3-1 in her matches last week in the Solheim Cup as the Americans defeated Europe for the first time in seven years.

“I’m looking forward to the stay-in-bed-all-day vibe today. It was definitely tough kind of waking up this morning, but I do love competing and I love being out here,” Korda said. “Everyone that played last week is going to be tired. I’m just trying to take it one step at a time, know that my energy levels aren’t the greatest, but I’m still motivated.”

She found additional motivation not so much from her five birdies but keeping a clean card.

“There is just no greater feeling than minimized your mistakes, or making no mistakes,” Korda said. “Whenever you get to play a bogey-free round I feel like it motivates you, and hopefully I can take that energy into the next three days.”

Maguire only played two matches last week, having played all five matches her previous two appearances. She wasn’t pleased about being sat out, especially after she easily disposed of Ally Ewing (4 and 3) in singles.

But maybe there was one upside.

“Last couple of Solheims I’ve played five matches, been exhausted after the Solheim,” she said. “So nice to be a little bit fresher time around.”

Korda and Maguire were part of a large group at 67 that included Lydia Ko, who last played three weeks ago and had every reason to be floating on air. Along with winning Olympic gold just over a month ago, she captured the Women’s British Open at St. Andrews.

Ko said her big summer — winning the gold medal got her into the LPGA Hall of Fame — still hasn’t sunk in. She arrived in the Cincinnati area having to learn a new course. The tournament was held at Kenwood Country Club the last two years, which is going through some improvements.

“It’s a new golf course, so all of us are just trying to get used to this TPC course and just putting ourselves in position,” Ko said. “And sometimes I think when you do see low scores, you try and chase it too much, but I just tried to stick to my own kind of routine and my strategy.”

Hamilton’s Alena Sharp had a 69, while Maude-Aimee Leblanc of Sherbrooke, Que., shot 71.

Rose Zhang went 4-0 in her matches at the Solheim Cup — needing only 58 holes — and finished with three straight bogeys for a 73. Esther Henseleit had a 74, and the other seven Solheim Cup players were at par or better.

___

AP golf:

The Canadian Press. All rights reserved.



Source link

Continue Reading

Trending